Carmen Fritz

Title: **Carmen Fritz: Innovating Pancreatin Production in Sun Prairie, WI**

Introduction

Carmen Fritz, an accomplished inventor based in Sun Prairie, Wisconsin, has made significant contributions to the field of biopharmaceutical manufacturing. With two patents to her name, she is at the forefront of developing methods to enhance the safety and efficiency of pancreatin production.

Latest Patents

Carmen's latest patents focus on innovative methods for reducing or inactivating viral and microbial content in pancreatin manufacturing processes. The first patent describes a method that integrates the use of peracetic acid (PAA) with pancreatin enzymes derived from animal sources, specifically porcine pancreas glands. The enzymes targeted in this patent include lipases, proteases, and amylases. The second patent expands on this concept by detailing a comprehensive method that involves treating animal-derived tissues with peracetic acid to minimize viral activity and bacterial load before processing. This advancement aims to ensure a safer pancreatin API by treating porcine pancreas glands prior to extraction.

Career Highlights

Carmen is currently affiliated with Scientific Protein Laboratories, LLC, where she applies her expertise to enhance the quality of pancreatin products. Her innovative approaches reflect her commitment to improving health outcomes through advancements in biotechnological methods.

Collaborations

In her role, Carmen collaborates with esteemed colleagues, including Kenneth S. Manning and Yan Wang, who share her passion for advancing biopharmaceutical manufacturing techniques. Together, they work towards ensuring that the production processes align with safety regulations while addressing the needs of patients.

Conclusion

Carmen Fritz’s groundbreaking work in reducing viral and microbial content in pancreatin manufacturing not only demonstrates her commitment to innovation but also enhances industry standards for safety and efficacy. As she continues to develop new technologies, her impact in the field of biotechnology and pharmaceuticals will undoubtedly contribute to significant advancements in patient care.